|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.700 USD | -0.58% |
|
-7.10% | +7.59% |
| Market Cap | 21Cr 18Cr 17Cr 16Cr 29Cr 1.95TCr 30Cr 201.04Cr 78Cr 963.98Cr 78Cr 76Cr 3.35TCr | P/E 2026 * |
-3.49x | P/E 2027 * | -5.7x |
|---|---|---|---|---|---|
| Enterprise Value | 21Cr 18Cr 17Cr 16Cr 29Cr 1.95TCr 30Cr 201.04Cr 78Cr 963.98Cr 78Cr 76Cr 3.35TCr | EV / Sales 2026 * |
172x | EV / Sales 2027 * | 4.52x |
| Free-Float |
82.58% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Outlook Therapeutics, Inc.
| 1 day | -0.58% | ||
| 1 week | -7.10% | ||
| Current month | +132.88% | ||
| 1 month | +132.88% | ||
| 3 months | +745.77% | ||
| 6 months | -14.14% | ||
| Current year | +7.59% |
| 1 week | 1.53 |  | 1.87 |
| 1 month | 0.68 | | 1.88 |
| Current year | 0.16 | | 1.88 |
| 1 year | 0.16 | | 3.39 |
| 3 years | 0.16 | | 37 |
| 5 years | 0.16 | | 65.4 |
| 10 years | 0.16 | | 878.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Jahr
CEO | Chief Executive Officer | 54 | 01/07/2025 |
Lawrence Kenyon
CEO | Chief Executive Officer | 60 | 03/12/2024 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 19/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Lawrence Kenyon
BRD | Director/Board Member | 60 | 02/08/2018 |
Kurt Hilzinger
BRD | Director/Board Member | 65 | 11/12/2015 |
| Chairman | 41 | 31/01/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02/06 | Buy | Director | 29,000 | 0.0181% | ||
| 28/05 | Gms Ventures & Investments
| Buy | Company | 3,95,16,849 | 24.6751% | |
| 27/05 | Buy | Chairman | 1,22,174 | 0.1471% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.58% | -7.10% | +6.25% | -94.79% | 21Cr | |
| +0.94% | +8.20% | -4.77% | +1.97% | 4.62TCr | |
| +5.45% | +15.38% | +420.02% | +629.65% | 3.87TCr | |
| -1.37% | +15.05% | +22.51% | -12.80% | 3.19TCr | |
| +3.97% | +6.04% | +19.06% | +61.39% | 3.11TCr | |
| +8.02% | +5.23% | +17.67% | +35.36% | 2.38TCr | |
| +36.91% | +14.98% | - | - | 1.62TCr | |
| -0.03% | +16.97% | +69.82% | +126.86% | 1.51TCr | |
| -1.13% | +9.05% | +12.03% | +18.95% | 1.37TCr | |
| +1.86% | +6.54% | +104.63% | +96.67% | 1.34TCr | |
| Average | +1.80% | +10.36% | +74.14% | +95.92% | 2.3TCr | |
| Weighted average by Cap. | +2.44% | +10.07% | +95.23% | +141.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 12L 10.51L 10L 9L 17.05L 11Cr 17.44L 1.17Cr 45.06L 5.6Cr 45.06L 44.08L 19Cr | 4.57Cr 4Cr 3.7Cr 3.45Cr 6.5Cr 432.33Cr 6.65Cr 44Cr 17Cr 213.28Cr 17Cr 17Cr 740.49Cr |
| Net income | -5.22Cr -4.57Cr -4.22Cr -3.94Cr -7.41Cr -493.33Cr -7.58Cr -51Cr -20Cr -243.38Cr -20Cr -19Cr -844.98Cr | -4.23Cr -3.71Cr -3.42Cr -3.2Cr -6.01Cr -400.21Cr -6.15Cr -41Cr -16Cr -197.44Cr -16Cr -16Cr -685.49Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | $1.695 | -0.88% | 71,08,902 |
| 26/26/26 | $1.710 | +6.21% | 1,14,91,945 |
| 25/26/25 | $1.610 | -4.17% | 91,47,785 |
| 24/26/24 | $1.680 | -1.18% | 86,76,520 |
| 23/26/23 | $1.700 | -7.10% | 1,07,92,078 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OTLK Stock
Select your edition
All financial news and data tailored to specific country editions
